Synthesis and characterization of 5,7-dihydroxyflavanone derivatives as novel protein tyrosine phosphatase 1B inhibitors. 2013

Liang-Peng Sun, and Wei-Ping Ma, and Li-Xin Gao, and Ling-Ling Yang, and Ying-Chun Quan, and Jia Li, and Hu-Ri Piao
Key Laboratory of Natural Resources of Changbai Mountain & Functional Molecules, Ministry of Education, Yanbian University College of Pharmacy , Yanji , China.

A series of 5,7-dihydroxyflavanone derivatives were synthesized and identified as reversible and competitive protein tyrosine phosphatase (PTP) 1B inhibitors with IC50 values in the micromolar range. Compound 4k had the most potent in vitro inhibition activity against PTP1B (IC50 = 2.37 ± 0.37 μM) and the greatest selectivity (3.7-fold) for PTP1B relative to T-cell protein tyrosine phosphatase. Cell-based studies revealed that 4k was membrane-permeable and enhanced insulin receptor tyrosine phosphorylation in CHO/hIR cells.

UI MeSH Term Description Entries
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D003412 Cricetulus A genus of the family Muridae consisting of eleven species. C. migratorius, the grey or Armenian hamster, and C. griseus, the Chinese hamster, are the two species used in biomedical research. Hamsters, Armenian,Hamsters, Chinese,Hamsters, Grey,Armenian Hamster,Armenian Hamsters,Chinese Hamster,Chinese Hamsters,Grey Hamster,Grey Hamsters,Hamster, Armenian,Hamster, Chinese,Hamster, Grey
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D016466 CHO Cells CELL LINE derived from the ovary of the Chinese hamster, Cricetulus griseus (CRICETULUS). The species is a favorite for cytogenetic studies because of its small chromosome number. The cell line has provided model systems for the study of genetic alterations in cultured mammalian cells. CHO Cell,Cell, CHO,Cells, CHO
D044950 Flavanones A group of FLAVONOIDS characterized with a 4-ketone. 2-Phenyl-Benzopyran-4-Ones,2 Phenyl Benzopyran 4 Ones

Related Publications

Liang-Peng Sun, and Wei-Ping Ma, and Li-Xin Gao, and Ling-Ling Yang, and Ying-Chun Quan, and Jia Li, and Hu-Ri Piao
April 2006, Bioorganic & medicinal chemistry letters,
Liang-Peng Sun, and Wei-Ping Ma, and Li-Xin Gao, and Ling-Ling Yang, and Ying-Chun Quan, and Jia Li, and Hu-Ri Piao
August 2003, Bioorganic & medicinal chemistry letters,
Liang-Peng Sun, and Wei-Ping Ma, and Li-Xin Gao, and Ling-Ling Yang, and Ying-Chun Quan, and Jia Li, and Hu-Ri Piao
December 2016, Molecules (Basel, Switzerland),
Liang-Peng Sun, and Wei-Ping Ma, and Li-Xin Gao, and Ling-Ling Yang, and Ying-Chun Quan, and Jia Li, and Hu-Ri Piao
June 2011, Bioorganic & medicinal chemistry letters,
Liang-Peng Sun, and Wei-Ping Ma, and Li-Xin Gao, and Ling-Ling Yang, and Ying-Chun Quan, and Jia Li, and Hu-Ri Piao
June 2012, Archiv der Pharmazie,
Liang-Peng Sun, and Wei-Ping Ma, and Li-Xin Gao, and Ling-Ling Yang, and Ying-Chun Quan, and Jia Li, and Hu-Ri Piao
April 2016, Bioorganic & medicinal chemistry letters,
Liang-Peng Sun, and Wei-Ping Ma, and Li-Xin Gao, and Ling-Ling Yang, and Ying-Chun Quan, and Jia Li, and Hu-Ri Piao
April 2023, Bioorganic & medicinal chemistry,
Liang-Peng Sun, and Wei-Ping Ma, and Li-Xin Gao, and Ling-Ling Yang, and Ying-Chun Quan, and Jia Li, and Hu-Ri Piao
April 2014, Die Pharmazie,
Liang-Peng Sun, and Wei-Ping Ma, and Li-Xin Gao, and Ling-Ling Yang, and Ying-Chun Quan, and Jia Li, and Hu-Ri Piao
December 2012, Bioorganic & medicinal chemistry letters,
Liang-Peng Sun, and Wei-Ping Ma, and Li-Xin Gao, and Ling-Ling Yang, and Ying-Chun Quan, and Jia Li, and Hu-Ri Piao
July 2005, Bioorganic & medicinal chemistry letters,
Copied contents to your clipboard!